Similar tenders from other countries.
Showing 1 to 20
Framework Agreement Cadry Condered National Program Hiv Aids
27 Feb 2025
27 Mar 2025Rfq-Dignity And Emergency Kits For Un Women Cox S Bazar Office
* Price Registration * Price Registration For Future Acquisition Of Medicines - Hiv/Aids 02. Protocol No. 23.146.702-5
Laboratory Diagnostic System And Reagents For The Execution Of The Confirmation Tests For Hiv 1 And 2, Hcv, Treponema With Immunoblot Technique
Supply of Medicine and Medical / Surgical equipments : Elisa Test kit for detection of HIV P24 antigen\nand antibodies to HIV; HIV 2 and HIV vi sub\ntype „O‟ antigen\n1. Test kit should detect of HIV P24 antigen\nand antibodies to HIV-1 (groups M and O)\nand HIV-2 inhuman serum or plasma.\n2. Number of tests shall be performed =480\ntests per kit\n3. Sensitivity should be 100%\n4. Specificity should be more than 99%\n5. Residual shelf life at the time of delivery\nshould be minimum of 18 months\n6. Each test kit should include adequate\npositive and negative controls\n7. Shall give a color change once serum is\nadded to the reagents.\n8. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as these\nreagents are kept at 2-6C.\n9. Reagent brochure, labels and any other\ninformation provided should be in English\nlanguage.\n10. Reagent shall contain FDA certification\nand/or WHO certification/ EU Quality\ncertification /free sales certificate and\ncertificate of use in the country in country of\norigin/ end user evaluation certificate/ or free\nsales certificate in USA, UK, France, Germany,\nCanada, New Zealand or Australia with\nstandard quality certificates etc .
Supply of Medicine and Medical / Surgical equipments : HIV Ag/Ab Combo Reagent for Analyzer\nCMIA technology-based HIV Ag/Ab Combo\nassay for blood donor screening.\nThe reagent kit shall be compatible with\nAlinitys Analyzer. CMIA HIV Ag/Ab Combo 4th\ngeneration assay should use two step\nchemiluminescent microparticle enzyme\nimmunoassay (CMIA) used for the\nsimultaneous qualitative detection of human\nimmunodeficiency virus (HIV) p24 antigen and\nantibodies to HIV type 1 (HIV-1 group M and\ngroup O and/or type 2 (HIV-2) in human serum\nand plasma, including specimens collected\npostmortem (non-heart-beating) to be used on\nAlinity s system for blood donor screening\npurposes. Ready To Use cartridges for the\neasy of use and less manual intervention.\nEach cartridge should be able to perform 500\ntests.\nThe reagent kit must be FDA approved for\nblood donor screening of HIV and certificates\nshall be attached.\nThe reagent kit must be NMRA approved for\nblood donor screening of HIV for blood and\nplasma donors.\nAll certificates of NMRA mentioning donor\nscreening purpose must be submitted for HIV\nAg/Ab Combo reagents.\nThe CMIA technology-based HIV Ag/Ab Combo\nassay should include calibrator kits, control\nkits, release control kits and reaction vessels\nalong with the reagent kits. At the time of\ndelivery expiery time shall be minimum of 10\nmonths.\nPacking : 500 tests etc .
Subject: Electronic Auction - Price Registration For Future Acquisition Of Medicines - Hiv/Aids 01. Protocol No. 23,148,238-5
Object: Electronic Auction - Price Registration For Eventual And Future Acquisition Of Medicines For The Treatment Of Opportunistic Infections, Intended For The State Coordination Of Hiv/Aids, Viral Hepatitis And Sexually Transmitted Infections, With The Objective Of Guaranteeing Assistance To Hiv/Aids Carriers, According To The Conditions, Specifications And Quantities Specified In The Terms Of Reference (Annex I) Of This Notice.
* Price Registry * Price Registry For Future Acquisition Of Medicines - Hiv/Aids 01. Protocol No. 23,148,238-5
* Price Registration * Price Registration, For A Period Of One Year, And May Be Extended For The Same Period, Provided That The Advantageous Price, For Future And Eventual Acquisition Of Hiv/Aids Medicines 01
Hiv Medications
Providing for for Medical Products for the ECOWAS Joint Assessment Procedure under the West Africa Medicines Regulatory Harmonization (WA-MRH)
FULL SERVICE services (with parts included), for vital signs monitors, defibrillators and ultrasound machines
Jilin Provincial Center For Disease Control And Prevention (Jilin Academy Of Preventive Medicine) Virus Institute Hiv Testing Related Reagents 36 Procurement Projects (First Package)
Annual Public Procurement Program For 2025
Provide Audit Services For The Project “Implementing Innovative Initiatives, Creating Evidence-Based Models For The National Hiv And Public Health Program And Enhancing Best Practices For Disease Control In Vietnam” For The Fiscal Year Ending December 31, 2024”
Annual Public Procurement Program For 2025
Annual Public Procurement Program For 2025
Hainan Provincial Women And Children'S Medical Center-2024 Hainan Province Prevention Of Mother-To-Child Transmission Of Hiv, Syphilis And Hepatitis B Reagents And Drugs Procurement Project.
Dk 021: 2015-33690000-3 Medicines Are Different (Reagents And Supplies Compatible With The Architect I1000Sr Devices)
Tenders by Country